Showing 5,901 - 5,920 results of 8,337 for search '"diabetes"', query time: 0.06s Refine Results
  1. 5901

    Coexistence of Ankylosing Spondylitis, Metabolic Syndrome and Gout Disease by Erkan Kozanoğlu, Meryem Andırın

    Published 2025-01-01
    “…Metabolic syndrome (MetS) is characterized by insulin resistance accompanied by systemic disorders, such as abdominal obesity, glucose intolerance or diabetes mellitus, dyslipidemia, hypertension, and coronary artery disease. …”
    Get full text
    Article
  2. 5902

    Blood glucose response to kratom tea (Mitragyna speciosa Korth.) by Fadly Dzul

    Published 2025-01-01
    “…Background: Kratoms are traditionally used in Borneo to manage diabetes by chewing, smoking, or brewing the leaves as tea. …”
    Get full text
    Article
  3. 5903

    A Severe Case of Arthrographis kalrae Keratomycosis by Siti Roszilawati Ramli, Alex Lourdes Francis, Yushaniza Yusof, Tzar Mohd Nizam Khaithir

    Published 2013-01-01
    “…A 52-year-old man with diabetes developed a unilateral central corneal ulcer after accidental foreign body inoculation. …”
    Get full text
    Article
  4. 5904

    Tuberculosis Presenting as Isolated Wrist Swelling: A Case Report and Review of Literature by Oshan Basnayake, Ahamed Nihaj, Ranji Pitagampalage, Harsha Mendis

    Published 2019-01-01
    “…A 53-year-old Sri Lankan male with long-standing diabetes presented with an isolated hand swelling for a 7-month duration. …”
    Get full text
    Article
  5. 5905

    Relationship between Periodontal Diseases and Preterm Birth: Recent Epidemiological and Biological Data by O. Huck, H. Tenenbaum, J.-L. Davideau

    Published 2011-01-01
    “…They influence negatively general health worsening cardiovascular diseases and diabetes. Periodontal diseases have been also suspected to increase the rate of preterm birth, but data remain contradictory. …”
    Get full text
    Article
  6. 5906

    Hybrid Clinical and Histopathological Pattern in Annular Lesions: An Overlap between Annular Elastolytic Giant Cell Granuloma and Granuloma Annulare? by Felipe Ladeira de Oliveira, Luisa Kelmer Côrtes de Barros Silveira, Alice de Miranda Machado, José Augusto da Costa Nery

    Published 2012-01-01
    “…An endocrine disease, such as diabetes mellitus (DM), could contribute to the coexistence of both lesions, and this possibility must be included in the medical investigation.…”
    Get full text
    Article
  7. 5907

    Pregnancy after Bariatric Surgery: A Review by N. L. Hezelgrave, Eugene Oteng-Ntim

    Published 2011-01-01
    “…It concludes that bariatric surgery appears to have positive effects on fertility and reduces the risk of gestational diabetes and preeclampsia. Moreover, there appears to be a reduced incidence of fetal macrosomia post-bariatric procedure, although there remains uncertainty about the increased rates of small-for-gestational age and intrauterine growth restricted infants, as well as premature rupture of membranes in this group. …”
    Get full text
    Article
  8. 5908

    Saphenovenous Graft Aneurysm: A Rare Complication of CABG by James Thomas Connell

    Published 2017-01-01
    “…We present the case of a 48-year-old male with a cardiovascular risk profile hallmarked by diabetes mellitus, end stage renal failure, recalcitrant hyperlipidaemia, and IHD previously treated with CABG. 11 years following his CABG, he was retrieved from remote Australia to a tertiary cardiology centre with stabbing chest pain. …”
    Get full text
    Article
  9. 5909

    Isolation of Streptococcus bovis in a Patient with Undiagnosed Colon Cancer. A Case Report by Ledys Pérez Morales, Jorge Emilio Barletta del Castillo, Odette Quiñones Cherta

    Published 2014-02-01
    “…Hence, it was decided to present the case of a 57-year-old patient from an urban area with a 6-year history of diabetes mellitus type I and alcoholism, who was admitted to the hospital in Cienfuegos because of significant gastrointestinal bleeding and fever (39-40 o C). …”
    Get full text
    Article
  10. 5910

    La nutrición materna y la programación metabólica: el origen fetal de las enfermedades crónicas degenerativas en los adultos by Asdrúbal Aguilera Méndez

    Published 2020-01-01
    “…Estas enfermedades son patologías de lenta evolución y no contagiosas como las involucradas en el síndrome metabólico que incrementa el riesgo de padecer diabetes tipo 2 y enfermedades cardiovasculares. En esta revisión se analizan los conceptos de síndrome metabólico, programación metabólica fetal, epigenética y factores nutricionales (desnutrición y sobrealimentación) relacionados con alteraciones en el desarrollo temprano de los individuos que condicionan en la edad adulta la aparición de enfermedades crónicas no transmisibles. …”
    Get full text
    Article
  11. 5911

    Unusual Presentation of a Rare Disease: A Case Report of Fungal Necrotizing Otitis Media and Mastoiditis by Ermia Mousavi Mohammadi, Mohsen Rajati, Hossein Zarrinfar

    Published 2025-01-01
    “…A 54‐year‐old female was presented who suffered from diabetes mellitus and end‐stage renal disease presenting with severe otalgia, initially thought to be necrotizing otitis externa. …”
    Get full text
    Article
  12. 5912

    Cardiovascular Complications in CKD Patients: Role of Oxidative Stress by Elvira O. Gosmanova, Ngoc-Anh Le

    Published 2011-01-01
    “…While traditional CVD risk factors, including diabetes, hypertension, hyperlipidemia, obesity, physical inactivity, may be more prevalent among CKD patients, these factors seem to underestimate the accelerated cardiovascular disease in the CKD population. …”
    Get full text
    Article
  13. 5913

    Pharma TARP: A Troubled Asset Relief Program for Novel, Abandoned Projects in the Pharmaceutical Industry by Tamas Bartfai, Graham Vaughan Lees

    Published 2011-01-01
    “…Society has a real need for the drugs that are no longer going to be developed for, among others, drug-resistant epilepsy, neuropathic and cancer pain, type-2 diabetes, obesity, and schizophrenia. The authors propose a radical response by the U.S. government and the National Institutes of Health to rescue these abandoned projects, and to continue selected programs for drug approval by the U.S. …”
    Get full text
    Article
  14. 5914

    Peroxisome Proliferator-Activated Receptor Agonists: Do They Increase Cardiovascular Risk? by Ahmad Aljada, Kshitij Ashwin Shah, Shaker A. Mousa

    Published 2009-01-01
    “…Cardiovascular disease is a major cause of morbidity and mortality among people with type 2 diabetes mellitus. The peroxisome proliferator-activated receptor (PPAR) agonists have a significant role on glucose and fat metabolism. …”
    Get full text
    Article
  15. 5915
  16. 5916

    Lactobacillus gasseri Causing Bilateral Empyema by Angela Esquibel, Ala S. Dababneh, Bharath Raj Palraj

    Published 2017-01-01
    “…This is a case of a 49-year-old male with previously undiagnosed type two diabetes mellitus who presented with a 3-month history of cough and was found to have right sided Lactobacillus gasseri empyema for which he underwent video-assisted thoracoscopic surgery (VATS) with chest tube placement. …”
    Get full text
    Article
  17. 5917

    PPARs: Protectors or Opponents of Myocardial Function? by Christine J. Pol, Melissa Lieu, Konstantinos Drosatos

    Published 2015-01-01
    “…Activators of PPARs are used for treating several metabolic complications, such as diabetes and hyperlipidemia that are directly or indirectly associated with HF. …”
    Get full text
    Article
  18. 5918

    Immunopeptidomics for autoimmunity: unlocking the chamber of immune secrets by Sanya Arshad, Benjamin Cameron, Alok V. Joglekar

    Published 2025-01-01
    “…We highlight the application of immunopeptidomics in Type 1 Diabetes (T1D), Systemic Lupus Erythematosus (SLE), and Rheumatoid Arthritis (RA). …”
    Get full text
    Article
  19. 5919

    Induction of Immunological Tolerance by Oral Anti-CD3 by Andre Pires da Cunha, Howard L. Weiner

    Published 2012-01-01
    “…Parenteral administration of anti-CD3 monoclonal antibody is an approved therapy for transplantation in humans and is effective in autoimmune diabetes. Orally administered anti-CD3 monoclonal antibody is biologically active in the gut and suppresses experimental models of autoimmune diseases. …”
    Get full text
    Article
  20. 5920

    Peroxisome Proliferator-Activated Receptors and the Heart: Lessons from the Past and Future Directions by Wang-Soo Lee, Jaetaek Kim

    Published 2015-01-01
    “…Several studies have demonstrated that PPAR agonists improve dyslipidemia and glucose control in animals, supporting their potential as a promising therapeutic option to treat diabetes and dyslipidemia. However, substantial differences exist in the therapeutic or adverse effects of specific drug candidates, and clinical studies have yielded inconsistent data on their cardioprotective effects. …”
    Get full text
    Article